Zenaida Mojares
Directeur Technique/Scientifique/R&D chez LAKESHORE BIOPHARMA CO., LTD
Profil
Zenaida Reynoso Mojares is currently the Chief Medical Officer at YS Biopharma Co. Ltd.
She previously worked as the Regional Director-Medical at Takeda Pharmaceuticals International AG from 2017 to 2020, as the Chief Medical Officer at GlaxoSmithKline Pte Ltd.
in 2015-2016, and as the Chief Medical Officer at the International Vaccine Institute from 2020 to 2022.
Dr. Mojares received her undergraduate degree from the University of Santo Tomas in 1979, her graduate degree from the University of the Philippines in 2004, her graduate degree from the University of Siena in 2011, and her doctorate from the University of Perpetual Help System Dalta in 1990.
Postes actifs de Zenaida Mojares
Sociétés | Poste | Début |
---|---|---|
LAKESHORE BIOPHARMA CO., LTD | Directeur Technique/Scientifique/R&D | 01/01/2022 |
Anciens postes connus de Zenaida Mojares
Sociétés | Poste | Fin |
---|---|---|
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Directeur Technique/Scientifique/R&D | 01/01/2022 |
Takeda Pharmaceuticals International AG
Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | 01/07/2020 |
GlaxoSmithKline Pte Ltd.
GlaxoSmithKline Pte Ltd. Pharmaceuticals: OtherHealth Technology GlaxoSmithKline Pte Ltd. engages in pharmaceutical products. It provides prescription medicines, vaccines, and consumer healthcare services. The company is headquartered in Gateway West, Singapore. | Directeur Technique/Scientifique/R&D | 01/02/2016 |
Formation de Zenaida Mojares
University of Santo Tomas | Undergraduate Degree |
University of the Philippines | Graduate Degree |
University of Siena | Graduate Degree |
University of Perpetual Help System Dalta | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
LAKESHORE BIOPHARMA CO., LTD | Health Technology |
Entreprise privées | 3 |
---|---|
Takeda Pharmaceuticals International AG
Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Health Technology |
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Commercial Services |
GlaxoSmithKline Pte Ltd.
GlaxoSmithKline Pte Ltd. Pharmaceuticals: OtherHealth Technology GlaxoSmithKline Pte Ltd. engages in pharmaceutical products. It provides prescription medicines, vaccines, and consumer healthcare services. The company is headquartered in Gateway West, Singapore. | Health Technology |